- Home
- EVRG vs WAT Comparison
EVRG vs WAT Comparison
Compare EVRG & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRG
- WAT
- Stock Information
- Founded
- EVRG 2017
- WAT 1958
- Country
- EVRG United States
- WAT United States
- Employees
- EVRG N/A
- WAT N/A
- Industry
- EVRG Power Generation
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- EVRG Utilities
- WAT Industrials
- Exchange
- EVRG Nasdaq
- WAT Nasdaq
- Market Cap
- EVRG 17.9B
- WAT 17.4B
- IPO Year
- EVRG N/A
- WAT 1995
- Fundamental
- Price
- EVRG $76.05
- WAT $373.32
- Analyst Decision
- EVRG Strong Buy
- WAT Buy
- Analyst Count
- EVRG 10
- WAT 13
- Target Price
- EVRG $77.35
- WAT $379.00
- AVG Volume (30 Days)
- EVRG 2.0M
- WAT 716.2K
- Earning Date
- EVRG 11-06-2025
- WAT 11-04-2025
- Dividend Yield
- EVRG 3.53%
- WAT N/A
- EPS Growth
- EVRG N/A
- WAT 3.82
- EPS
- EVRG 3.66
- WAT 10.88
- Revenue
- EVRG $5,878,800,000.00
- WAT $3,105,638,000.00
- Revenue This Year
- EVRG $5.19
- WAT $7.12
- Revenue Next Year
- EVRG $3.76
- WAT $6.22
- P/E Ratio
- EVRG $20.67
- WAT $34.13
- Revenue Growth
- EVRG 1.75
- WAT 6.90
- 52 Week Low
- EVRG $59.67
- WAT $275.05
- 52 Week High
- EVRG $79.32
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- EVRG 44.97
- WAT 73.04
- Support Level
- EVRG $76.00
- WAT $340.09
- Resistance Level
- EVRG $77.61
- WAT $382.02
- Average True Range (ATR)
- EVRG 1.14
- WAT 11.56
- MACD
- EVRG -0.39
- WAT 1.40
- Stochastic Oscillator
- EVRG 29.45
- WAT 81.72
About EVRG Evergy Inc.
Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission Co. The utility has a combined rate base of approximately $20 billion, about half in Kansas and the rest split between Missouri and federal jurisdiction. Evergy is one of the largest wind energy suppliers in the US.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.